Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

qq; I didn't see your post until now. I agree. I think Novartis will be the front runner here. They must have liked the deal Denner put together for the Medco sale. I think Vascepa is a superior product in all respects over Inclirsiran. Heck, Vascepa alone is a drug for Statin intolerant folks, besides Vascepa is also a drug for Type 2 Diabetics as less we forget it helps to normalize Glycemic levels as I recall? And don't forget about the BRAVE study coming out next year. This will put Vascepa on a different level than we realize.

Often times, rumors turn out to be truths.

GLTA
Nuke